PABPC4 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.58733051544868E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.88969997824995E-09 |
Normal-vs-Stage2 |
7.999000E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.524900E-03 |
Stage1-vs-Stage2 |
1.546820E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.162000E-03 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
3.037200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.05464592193539E-12 |
Normal-vs-AfricanAmerican |
2.749800E-01 |
Normal-vs-Asian |
1.798610E-01 |
Caucasian-vs-AfricanAmerican |
4.838200E-01 |
Caucasian-vs-Asian |
6.235200E-01 |
AfricanAmerican-vs-Asian |
6.551400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.30139999999324E-05 |
Normal-vs-Female |
3.91379999520325E-08 |
Male-vs-Female |
3.921400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.323570E-03 |
Normal-vs-Extreme_Weight |
3.50500000000364E-05 |
Normal-vs-Obese |
1.304850E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.718800E-01 |
Normal_Weight-vs-Obese |
4.684400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
4.467000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.176000E-01 |
Normal-vs-Age(41-60Yrs) |
1.359630E-04 |
Normal-vs-Age(61-80Yrs) |
5.9660998363853E-10 |
Normal-vs-Age(81-100Yrs) |
5.156800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.316800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.808400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.882800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.093370E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.096600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.851600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.268300E-02 |
Normal-vs-Grade 3 |
3.605700E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
4.543600E-01 |
Grade 2-vs-Grade 4 |
5.268300E-02 |
Grade 3-vs-Grade 4 |
3.605700E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.23159968071718E-10 |
Normal-vs-N1 |
1.137700E-02 |
N0-vs-N1 |
8.913500E-02 |
|
|